---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-029812"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2026-05-04T23:59:59+00:00"
generated_at: "2026-05-15T00:10:59.672001+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Medifast Q1 revenue $76M, down 34% YoY; net loss $2.1M; guides Q2 revenue $60-80M

## Summary
- Revenue fell 34.3% to $76.0M; net loss widened to $2.1M ($0.19 EPS) from $0.8M loss.
- Active earning coaches dropped 44.9% to 14,000; rev per coach up 19.2% to $5,432.
- Gross margin 68.1% vs 72.8% a year ago; operating loss $3.3M vs $1.3M.
- Outlook: Q2 rev $60-80M, EPS loss $0.50-$1.00; FY rev $270-300M, EPS loss $1.55-$2.75.
- Cash $168.9M, no debt; expects active earning coaches to continue declining in 2026.

## SEC filing metadata
- accession: 0001628280-26-029812
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2026-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828026029812/0001628280-26-029812-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828026029812/med-20260504.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-029812
- JSON: https://secwatch.observer/filing/0001628280-26-029812.json
- Plain text: https://secwatch.observer/filing/0001628280-26-029812.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
